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Abstract
Background The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and 
media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing 
of harmful diseases. We explored the rates of emergency presentations for acute coronary syndrome (ACS) and acute cer-
ebrovascular events (ACVE) before and after spread of SARS-CoV-2.
Methods We analyzed all-cause visits at a tertiary university emergency department and admissions for ACS and ACVE 
before (calendar weeks 1–9, 2020) and after (calendar weeks 10–16, 2020) the first coronavirus disease (COVID-19) case 
in the region of the Saarland, Germany. The data were compared with the same period of the previous year.
Results In 2020 an average of 346 patients per week presented at the emergency department whereas in 2019 an average of 
400 patients presented up to calendar week 16 (p = 0.018; whole year 2019 = 395 patients per week). After the first COVID-
19 diagnosis in the region, emergency department visit volume decreased by 30% compared with the same period in 2019 
(p = 0.0012). Admissions due to ACS decreased by 41% (p = 0.0023 for all; Δ − 71% (p = 0.007) for unstable angina, Δ 
− 25% (p = 0.42) for myocardial infarction with ST-elevation and Δ − 17% (p = 0.28) without ST-elevation) compared with 
the same period in 2019 and decreased from 142 patients in calendar weeks 1–9 to 62 patients in calendar weeks 10–16. 
ACVE decreased numerically by 20% [p = 0.25 for all; transient ischemic attack: Δ − 32% (p = 0.18), ischemic stroke: Δ 
− 23% (p = 0.48), intracerebral haemorrhage: Δ + 57% (p = 0.4)]. There was no significant change in ACVE per week (p = 0.7) 
comparing calendar weeks 1–9 (213 patients) and weeks 10–16 (147 patients). Testing of 3756 samples was performed 
to detect 58 SARS-CoV-2 positive patients (prevalence 1,54%, thereof one patient with myocardial and two with cerebral 
ischemia) up to calendar week 16 in 2020.
Conclusions The COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions 
due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical 
decrease but no significant difference.
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Introduction
The ongoing pandemic of the novel coronavirus SARS-
CoV-2 disease (COVID-19) unsettles people worldwide 
and has led to 287,399 deaths globally by May 13, 2020 
[1]. To protect the local health system from overload and to 
maintain intensive care capacities for COVID-19 patients, 
elective admissions have been reduced and postponed. In 
addition to hygiene advices, the World Health Organization 
(WHO) strongly recommends limiting face-to-face contact 
with others via social distancing [2]. Subsequently, changes 
in the pattern of hospital admissions have been observed 
[3–6]. Valuable time passes with the ubiquitous differential 
diagnosis of respiratory insufficiency caused by COVID-19, 
which is frequently aimed to exclude before detailed exami-
nations (e.g., physical examination, ultrasound, computed 
tomography, coronary angiography) take place [7]. There-
fore, concerns have been raised regarding underdiagnosing 
of harmful but treatable cardiovascular diseases.
Methods
Study design and patients
We analyzed ICD-10-GM (International Statistical Classifi-
cation of Diseases and Related Health Problems, 10th Revi-
sion, German Modification) codes from discharge letters at 
Saarland University Medical Center, Germany, during cal-
endar weeks 1–16 of the years 2019 and 2020, respectively. 
We assessed the all-cause visit volume at the emergency 
department of Internal Medicine (aged ≥ 18 years) and Sur-
gery (aged ≥ 0 years). Digital records of patients admitted for 
acute coronary syndrome (ACS), including unstable angina 
pectoris as well as myocardial infarction with (STEMI) or 
without (NSTEMI) ST-elevation were evaluated. Similarly, 
the number of acute cerebrovascular events (ACVE), includ-
ing transient ischemic attack, ischemic stroke, and intracer-
ebral haemorrhage were evaluated. We compared calendar 
weeks 1–9 before the first COVID-19 case in the region of 
Saarland (1st case on March 3rd, calendar week 10) with 
calendar weeks 10–16, during which the infection numbers 
in the region increased. Focus was also given on the timing 
of the shutdown in the Saarland (March 16th, calendar week 
12). To reduce bias due to seasonal effects, we compared 
the visit volume with the same period of the previous year.
RT‑PCR‑based diagnostic of COVID‑19
The indication for COVID-19 testing was performed accord-
ing to the recommendations of the Robert Koch Institute 
[8]. COVID-19 confirmation test was performed by isolated 
RNA from eSwabs (Copan Italia, Brescia, Italy) using the 
NucliSens easy MAG Instrument (bioMeriéux Deutschland, 
Nürtingen, Germany) following the manufacturers’ instruc-
tions. PCR amplification used the RealStar SARS-CoV-2 
RT-PCR Kit 1.0 RUO (Altona Diagnostics, Hamburg, Ger-
many) on a Light Cycler 480 II Real-Time PCR Instrument 
(Roche Diagnostics Deutschland, Mannheim, Germany) 
according to the manufacturers’ instructions [9]. From 
week 12 on COVID-19 confirmation was additionally per-
formed with the  cobas® SARS-CoV-2 Test for the  cobas® 
6800 instrument (Roche Diagnostics GmbH, Mannheim, 
Germany) according to manufacturers’ instructions. Only 
tests from patients at the Saarland University Medical Center 
were included in the analyses, tests from staff were excluded.
Statistics
Data are presented as mean unless otherwise specified. Cat-
egorical variables are presented as numbers (%). Variables 
were tested for normality utilizing the Shapiro–Wilk test. 
For continuous variables, between-group comparisons were 
performed using the Mann–Whitney or Wilcoxon rank-sum 
test and Kruskal–Wallis-test where appropriate. Significance 
tests were two-tailed with p < 0.05 considered significant. 
All statistical analyses were performed using GraphPad 
Prism version 8.2.1 (GraphPad Software, La Jolla, CA, 
USA).
Results
Emergency department visit volume
At the emergency department in 2020 an average of 346 
patients per week presented up to calendar week 16 whereas 
in 2019 an average of 400 patients per week presented 
(p = 0.018) over the same period of time. In 2020, admis-
sions at the emergency department decreased by calendar 
week 8 parallel to the occasional detection of COVID-19 in 
Germany (Fig. 1). After verification of the first patient with 
COVID-19 in the Saarland region on March 3, 2020 (cal-
endar week 10), the number of admissions dropped, regard-
less of the reason for admission (average of 397 patients per 
week in calendar weeks 1–9 vs. average of 279 patients per 
week in calendar weeks 10–16, p = 0.016) (Fig. 2a).There 
was no significant difference for the average visit volume 
when comparing weeks 1–9 of 2020 with 2019. After the 
first COVID-19 diagnosis in the region, all-cause emergency 
department visit volume decreased by 30% compared with 
the same period in 2019 (1954 patients in 2020 vs. 2773 
patients in 2019 at calendar weeks 10–16, p = 0.0012) and 
tended to further decrease by 36% after the shutdown in 
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the Saarland compared with the same period in 2019 (1260 
patients in 2020 vs. 1959 patients in 2019 at calendar weeks 
12–16, p = 0.008). In parallel to the regional shutdown, the 
nadir was reached at calendar weeks 12–13. Following cal-
endar week 14, the visit volume at the emergency depart-
ment increased again but remained significantly lower com-
pared with the previous year.
Acute coronary syndrome in the emergency 
department
After the first laboratory-confirmed SARS-CoV-2 infection 
in calendar week 10 of 2020 in the Saarland, the number of 
patients diagnosed with an ACS decreased significantly by 
41% compared with the previous year (62 patients in 2020 vs. 
105 patients in 2019 at calendar weeks 10–16, p = 0.0023) 
(Fig. 3). During the shutdown in calendar weeks 12–16, 
there was a further reduction of patients who admitted with 
ACS compared with the previous year (Δ − 48%, 39 patients 
in 2020 vs. 75 patients in 2019 at calendar weeks 12–16, 
p = 0.008). There was no significant difference in admis-
sion rates when comparing week 1–9 of the years 2020 to 
2019. Regarding the different entities of ACS, we observed 
a significant decrease in unstable angina by 71% after the 
first confirmed COVID-19 patient in the region (12 patients 
in 2020 vs. 42 patients in 2019, p = 0.007) respectively a 
decrease by 85% during the lockdown (4 patients in 2020 vs. 
27 patients in 2019, p = 0.008) compared with the previous 
year. The decline in STEMI (Δ − 25% in calendar weeks 
10–16, 21 patients in 2020 vs. 28 patients in 2019, p = 0,42; 
Δ − 41% in calendar weeks 12–16, 13 patients in 2020 vs. 
22 patients in 2019, p = 0.25) and NSTEMI (Δ − 17% in 
calendar weeks 10–16, 29 patients in 2020 vs. 35 patients 
in 2019, p = 0.28; Δ − 19% in calendar weeks 12–16, 22 
patients in 2020 vs. 29 patients in 2019, p = 0.4) was not 
significant. However, in weeks 1–9 more ACS were treated 
compared with period after the first confirmed COVID-19 
case in the region (142 patients in calendar weeks 1–9 vs. 
62 patients in calendar weeks 10–16, p = 0.0007) (Fig. 2b).
Acute cerebrovascular events
Admissions due to ACVE, including transient ischemic 
attack, ischemic stroke, and intracerebral haemorrhage 
were numerically reduced by 20% at calendar week 10 
(147 patients in 2020 vs. 183 patients in 2019, p = 0.25) 
and by 31% during shutdown (98 patients in 2020 vs. 
143 patients in 2019, p = 0.14) compared with the same 
period last year (Fig. 4). Looking at the individual enti-
ties at calendar week 10–16 and under lockdown condi-
tions compared to the same period in 2019 there was a 
non-significant reduction by 32% (41 patients in 2020 
vs. 60 patients in 2019, p = 0.18) and 34% (31 patients in 
2020 vs. 47 patients in 2019, p = 0.2) of transient ischemic 
attack, a 23% (84 patients in 2020 vs. 109 patients in 
2019, p = 0.48) and 34% (57 patients in 2020 vs. 86 
patients in 2019, p = 0.25) non-significant reduction of 
ischemic strokes as well as a 57% (22 patients in 2020 vs. 
14 patients in 2019, p = 0.4) and 0% (10 patients in 2020 
vs. 10 patients in 2019, p = 1) also not significant increase 
Fig. 1  Emergency department visit volume. Comparison of the num-
ber of patients during calendar weeks 1–16 in 2019 and 2020
Fig. 2  Box plot of patients at calendar weeks 1–9 and 10–16 in the year 2020. a Emergency department visit volume. b Acute coronary syn-
drome. c Combination of ischemic stroke, transient ischemic attack (TIA) and intracerebral haemorrhage (ICH)
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in intracerebral haemorrhage. There was no significant 
difference when comparing the mean number of presenta-
tions per week for acute cerebral events at week 1–9 and 
10–16 of the year 2020 (24 patients per week in 2020 vs. 
8 patients per week in 2019, p = 0.7) (Fig. 2c).
Virological test volume for COVID‑19
With spread of the infection the test volume for SARS-
CoV-2 testing increased week to week (one test in cal-
endar week 6, 965 tests in calendar week 16; Fig. 5). In 
our analyses during end of week 16 in 2020, testing of 
3765 samples detected 58 positive patients. The over-
all rate of positive tests from patients of the Saarland 
University Medical Center up to calendar week 16 was 
1.54%. We identified one patient with acute myocardial 
infarction and one patient with ACVE with coinciden-
tal SARS-CoV-2 infection. One patient with previously 
known COVID-19 infection was admitted with an acute 
cerebrovascular event.
Discussion
At the Saarland University hospital, a tertiary referral center, 
a significant decrease in medical contacts at the emergency 
department and the number of patients presenting with ACS 
was documented during the first wave of the COVID-19 pan-
demic. This was mainly driven due to an 85% decrease in 
admission for unstable angina during shutdown conditions 
whereas the reduction in admissions caused by myocardial 
infarction was not significant. Regarding acute cerebrovascu-
lar events there was a numerically reduction in our analyses.
During the past weeks, reports on increasing numbers of 
COVID-19 positive patients in China, US and Europe domi-
nated the reporting in the lay press and resulted in pressure 
on health care systems like in Northern Italy. This coverage 
led to great fear and uncertainty in several countries, includ-
ing Germany [10]. In England attendances at the emergency 
department have fallen by 25% the week after the prime 
minister Boris Johnson announced a lockdown on 23 March 
[11]. Similar decline of emergency department visits could 
Fig. 3  Acute coronary syndrome. a Accumulated number of patients 
with acute coronary syndrome in the emergency department at cal-
endar weeks 1–16 in the year 2019 and 2020. Number of patients 
at calendar weeks 1–16 in the year 2019 and 2020 with myocardial 
infarction with (b, STEMI) and without (c, NSTEMI) ST-elevation 
and unstable angina (d)
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also be observed for paediatric emergency department visits 
[6]. To exclude a seasonal effect in the analyses, we com-
pared the visit volume with the same period of the previous 
year. Proportionally more patients who had been admitted 
to the emergency department subsequently required inpa-
tient treatment, indicating that consultations for less severe 
reasons decreased. In calendar weeks 15–16, the emergency 
department visit volume graphs of 2019 and 2020 get closer, 
which may have several reasons like behavior and travelling 
attitudes. Exemplarily, Christmas and Midsummer holidays 
have been associated with higher risk of myocardial infarc-
tion; a weekend-effect with delay in coronary angiogra-
phy for NSTEMI resulting in a higher mortality has been 
described [12, 13]. Behavior during the Easter holidays may 
have been different in 2020 due to the government restric-
tions in Germany. In 2019 (Easter at calendar week 16), the 
festivity with the family and/or a short vacation was obvious, 
so that more trivial health problems potentially were solved 
Fig. 4  Acute cerebrovascular events. a Accumulated number of 
patients with ischemic stroke, transient ischemic attack (TIA) and 
intracerebral haemorrhage (ICH) at calendar weeks 1–16 in the year 
2019 and 2020. Number of patients at calendar weeks 1–16 in the 
year 2019 and 2020 with ischemic stroke (b), TIA (c) and ICH (d)
Fig. 5  Virological test volume for SARS-CoV-2 for patients at the 
Saarland University Medical Center
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in the family itself and a relevant number of people were 
located abroad. In 2020 (Easter at calendar week 15) neither 
a family visit nor a journey was allowed due to the lockdown 
in our region. Patients who had previously postponed their 
doctor’s appointment may have gone to see a doctor due to 
the increasing level of suffering.
We found an “atypical” low number of cardiovascular 
events compared with the weeks before the regional out-
break of the pandemic and compared with the same period 
of the previous year. A similar trend was observed in cardio-
vascular centers in Austria [14], the severely affected North-
ern Italy [3] and Iran [15]. It can be assumed by a stable 
incidence of patients having an ACS that patients abstain 
from seeing a doctor despite symptoms of acute myocardial 
ischemia. This is in line with the increasing number of out-
of-hospital cardiac arrest in Italy compared with the same 
period in 2019 [4]. In COVID-19 patients, cardiac injury 
is a common feature whereby the mechanisms have not yet 
been finally clarified [16]. In our analyses, there was only 
one patient with myocardial infarction who was tested posi-
tive for the virus, but regarding a total number of 62 patients 
presenting with ACS the ratio was 1,6%—and is therefore 
in the area of the overall prevalence in our hospital. A sig-
nificant reduction in catheterization laboratory activations 
during COVID-19 pandemic due to a decline in patients with 
STEMI was observed in the US [17].
Although the difference was not statistically significant, 
we documented a numerically lower number of transient 
ischemic attacks and ischemic strokes. According to the 
World Stroke Organization there is a significant fall in stroke 
presentations globally [5]. One may speculate that patients 
with mild or moderate symptoms refrain from consulting 
health care providers. The increase in intracerebral haem-
orrhage could be (1) directly attributed to underdiagnosed 
and therefore undertreated cerebral ischemia, (2) less strictly 
controlled blood pressure values due to reduced contacts 
with doctors or (3) an increase of accidents in the household 
(e.g., due to self-made construction work or family violence 
during the shutdown and government restrictions) [18–21].
Coagulopathy, inflammatory responses, and endothe-
lial dysfunction are associated with COVID-19 [22–24]. 
As a result of this, with (symptomatic as well as asympto-
matic) spread of SARS-CoV-2 infection an increased rate 
of acute cardiovascular and acute cerebrovascular events 
can be assumed [25]. The reduction in ED numbers was 
not substantiated by an objective increase of COVID-19 
infections. Despite testing the day of admission, by now, 
we identified only one patient with acute myocardial infarc-
tion and one patient with acute cerebrovascular event with 
coincidental SARS-CoV-2 infection. In addition, only one 
patient with previously known COVID-19 was admitted 
with an acute cerebrovascular event. Given the overall low 
number of positive test at our hospital, patients’ concern 
about an increased risk of infection in the hospital appears 
unsubstantiated.
As a result of the legal provisions that no non-urgent or 
preventive medical examinations should take place dur-
ing the shutdown, it can be assumed that a high rate of 
underdiagnosed diseases can be expected. The general 
recommendation to reduce social contacts in everyday life 
wherever and whenever possible led more people to stay 
at their presumed safe homes. This recommendation could 
have impaired respectively delayed scheduled and unsched-
uled doctor visits. Whether the rate of successfully treated 
COVID-19-positive patients outweighs the high number of 
undiagnosed diseases caused by the shutdown remains to 
be answered. It would be fatal if there would be an increase 
in deaths—especially in those without COVID-19 having 
harmful, but treatable diseases.
Limitations
Patients presented directly at the department of neurology 
and pediatrics or transferred directly to specialized depart-
ments were not included in the analysis of the total number 
of patients presented at the central emergency department 
at the Saarland University Medical Center.
Conclusions
The COVID-19 pandemic is associated with a significant 
decrease in all-cause admission and admissions due to acute 
cardiovascular and potentially cerebrovascular events in the 
emergency department. Regarding acute cerebrovascular 
events there was a numerical difference which needs to be 
scrutinized in large sample series. Increase of test capacity 
adapted to the pandemic process up to the general testing for 
inpatients has been succeeded in order to be able to maintain 
standard medical care and offers chances to restart indicated 
preventive medicine. Essential part of successful medical 
treatment maintains the step that the patient comes to see 
a doctor at all. As a result of these observations, regional 
media campaigns as already started are important to encour-
age patients to continue to see a doctor if they have health-
related problems.
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